GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

Eco Science Solutions ESSI · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.18

+146.24%

Close of 3 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2021

Revenue

$52,728

FY2014FY2021

Net income

−$106,317

FY2014FY2021

Free cash flow

−$388,295

FY2014FY2021

Shareholders' equity

−$11.0m

FY2014FY2021

Income statement

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue$52,728$59,729——————
Research and development$153,275$157,837$657,948$670,480$305,092$74,750$74,750$360
Operating income−$1.2m−$1.5m−$4.2m−$4.3m−$24.8m−$725,519−$1.1m−$2.2m
Net income−$106,317−$1.9m−$4.8m−$22.9m−$33.6m−$909,716−$1.1m−$7.8m
Diluted earnings per share-0.00-0.04-0.09-0.43-0.64-0.02-0.02-0.15

Balance sheet

At each fiscal year end

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Total assets$4,907$61,051$154,733$158,605$246,575$6,706$13,322$6,000
Total liabilities$11.0m$11.3m$9.5m$4.8m$1.0m$763,221$523,771$385,000
Debt$350,000—$6.3m$3.4m$613,210$530,205$422,395$577,991
Shareholders' equity−$11.0m−$11.2m−$9.4m−$4.7m−$774,427−$756,515−$510,449−$5.6m
Shares outstanding53m53m53m53m53m53m53m53m

Cash flow

Fiscal years

FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations−$388,295−$787,142−$2.4m−$2.7m−$366,030−$72,866−$140,066−$105,053
Capital spending———−$13,266−$2,262−$2,262−$2,262−$2,262
Free cash flow−$388,295−$787,142−$2.4m−$2.7m−$368,292−$75,128−$142,328−$107,315

Latest quarters

By quarter end

Jan 2021Oct 2020Jul 2020Apr 2020Jan 2020Oct 2019Jul 2019Apr 2019
Revenue−$400$15,429$17,427$20,226$46,338$13,391——
Operating income−$562,900−$300,689−$194,565−$110,145−$433,180−$246,871−$363,617−$454,167
Net income$1.2m−$871,914−$258,966−$172,947−$496,834−$434,908−$423,433−$511,455
Diluted earnings per share0.03-0.02-0.00-0.00-0.01-0.01-0.01-0.01
Total assets$4,900$60,657$58,094$55,708$61,051$50,359$159,284$172,553
Cash and short-term investments$4,900———————
Debt$7.8m————$6.9m$6.6m$6.5m
Shareholders' equity−$11.0m−$12.5m−$11.7m−$11.4m−$11.2m−$10.7m−$10.3m−$9.9m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-35.1%10.0%37.0%
Net income-83.3%-34.9%7.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-2370.8%———
Net margin-1754.4%———

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return31727%0%0%300%3203%27695%17716066%-11%-96%72920%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 25-to-1 reverse split · 4 May 2026
  • 1000-to-1 reverse split · 25 Feb 2014
  • 6-for-1 split · 2 Apr 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.